Results 71 to 80 of about 16,351,427 (307)
Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Diabetes‐associated cognitive impairment (DACI) is a common yet underrecognized condition, manifesting along a spectrum from mild cognitive impairment to dementia. DACI encompasses patients who develop vascular dementia (VaD) or Alzheimer's disease (AD) with diabetes as a risk factor; however, in certain patients, particularly those lacking ...
Osman Corbali +4 more
wiley +1 more source
International Competitiveness of Sugar Production [PDF]
Sugar market is one of the most protected markets for agricultural products world wide. In almost every sugar producing country the sugar market is regulated in some way.
Zeddies, Jurgen, Zimmermann, Beate
core
High-sugar sweet corn hybrids in southern California
California Agriculture, 1977 No new hybrids have yet ben introduced, but some of the hybrids tested have many god qualities. Characteristics evaluated include plant vigor, ear length, husk cover, kernel swetnes and tendernes, and tolerance to ozone air polution.
J Cameron
doaj
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective The aim of this study was to characterize intellectual and motor function, neurological features including epilepsy, treatment response, and adaptive behavior in patients with pyruvate dehydrogenase complex deficiency (PDCD) in Sweden.
Antri Savvidou +6 more
wiley +1 more source
CHANGES IN THE U.S. DEMAND FOR SUGAR AND IMPLICATIONS FOR IMPORT POLICIES [PDF]
The thrust of this paper is to identify and measure structural changes in the U.S. demand for sugar and to derive subsequent implications for import restriction policies.
Sepulveda, Jorge L., Lopez, Rigoberto A.
core
Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Dysregulated lipid metabolism, which can affect remyelination and neural repair, has not been extensively investigated in progressive multiple sclerosis (PMS). The goal was to examine whether dysregulated cholesterol metabolism was associated with disability in PMS. Methods The study sample comprised 53 Severe PMS patients (Expanded
Taylor R. Wicks +8 more
wiley +1 more source
IMPACT OF AGRICULTURAL BIOTECHNOLOGY IN THE EUROPEAN UNION'S SUGAR INDUSTRY [PDF]
We develop a welfare framework, which explicitly recognizes that research protected by intellectual property rights generates monopoly profits. The result is a simulation model, shaped to the European sugar sector, and enabling to assess the size and ...
Tollens, Eric, Demont, Matty
core